Plaque vulnerability and adverse outcomes: The long road to fight atherosclerosis-Reference-Cited by-同舟云学术

Plaque vulnerability and adverse outcomes: The long road to fight atherosclerosis

Published:2020-05-15 Issue:6 Volume:50 Page:
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur J Clin Invest

Author:

Bonaventura Aldo¹²^ORCID,Liberale Luca²³^ORCID,Carbone Federico²⁴^ORCID,Vecchié Alessandra¹²^ORCID,Montecucco Fabrizio⁴⁵^ORCID

Affiliation:

1. Pauley Heart Center Division of Cardiology Department of Internal Medicine Virginia Commonwealth University Richmond VA USA

2. First Clinic of Internal Medicine Department of Internal Medicine University of Genoa Genoa Italy

3. Center for Molecular Cardiology University of Zurich Schlieren Switzerland

4. IRCCS Ospedale Policlinico San Martino Genova – Italian Cardiovascular Network Genoa Italy

5. First Clinic of Internal Medicine Department of Internal Medicine and Centre of Excellence for Biomedical Research (CEBR) University of Genoa Genoa Italy

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/eci.13253

Reference32 articles.

1. Exploring the role of extracellular matrix proteins to develop biomarkers of plaque vulnerability and outcome

2. Systemic and Intraplaque Mediators of Inflammation Are Increased in Patients Symptomatic for Ischemic Stroke

3. Leptin/adiponectin ratio predicts poststroke neurological outcome

4. Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes

5. Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery Stenosis

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the impact of aging and blood pressure on dermal microvasculature by reactive hyperemia optical coherence tomography angiography;Scientific Reports;2021-06-28

2. Clustering of blood cell count abnormalities and future risk of death;European Journal of Clinical Investigation;2021-05-07

3. Intermedin1-53 attenuates atherosclerotic plaque vulnerability by inhibiting CHOP-mediated apoptosis and inflammasome in macrophages;Cell Death & Disease;2021-05